Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This project will investigate the ability of a novel MRI contrast agent to identify and
quantitate ongoing monocyte/macrophage (M/MΦ)-mediated inflammation in the brains of
HIV-infected individuals.
Phase:
Phase 2
Details
Lead Sponsor:
Beau Nakamoto
Collaborators:
Hawaii Pacific Health National Institute of Neurological Disorders and Stroke (NINDS) University of Hawaii